Robert Hague Centre for Diabetes and Endocrinology, Barnsley Hospital NHS Foundation Trust, Barnsley, UK.
Trends Endocrinol Metab. 2010 Aug;21(8):496-503. doi: 10.1016/j.tem.2010.03.002. Epub 2010 Apr 8.
Male gender is a major risk factor for premature cardiovascular death, a relationship not yet explained. Low testosterone in men is a risk factor for the metabolic syndrome and type 2 diabetes and is associated independently with individual components of the metabolic syndrome--visceral obesity, insulin resistance, hyperglycemia, hypertension and dyslipidemia. Epidemiological studies report increased mortality in men with low testosterone. Testosterone replacement in the short-term reduces waist circumference, cholesterol and circulating pro-inflammatory cytokines and improves insulin sensitivity and glycemic control in diabetics. Testosterone also has beneficial effects on cardiac ischemia, angina and chronic heart failure. This manuscript reviews the current evidence supporting a link between low testosterone and cardiovascular disease, highlighting the need for larger, longer-term studies.
男性性别是导致心血管疾病过早死亡的主要危险因素,但其中的关系尚未得到解释。男性体内睾丸酮水平低是代谢综合征和 2 型糖尿病的一个风险因素,并且与代谢综合征的各个组成部分——内脏肥胖、胰岛素抵抗、高血糖、高血压和血脂异常——独立相关。流行病学研究报告称,睾丸酮水平低的男性死亡率更高。短期的睾丸酮替代治疗可降低腰围、胆固醇和循环促炎细胞因子水平,并改善糖尿病患者的胰岛素敏感性和血糖控制。睾丸酮对心肌缺血、心绞痛和慢性心力衰竭也有有益的影响。本文综述了目前支持睾丸酮水平低与心血管疾病之间存在关联的证据,强调需要进行更大规模、更长期的研究。